Ana Dordea Nicholson PhD
About Ana Dordea Nicholson PhD
Ana Dordea Nicholson, PhD, serves as the Director of R&D Strategy at Generate Biomedicines, Inc. in Cambridge, Massachusetts, bringing over a decade of experience in R&D and commercial strategy across multiple countries.
Current Role at Generate Biomedicines
Ana Dordea Nicholson serves as the Director of R&D Strategy at Generate Biomedicines, Inc. since 2022. In this role, she focuses on developing and implementing research and development strategies that align with the company's objectives. Generate Biomedicines is located in Cambridge, Massachusetts, and is known for its innovative approaches in the biopharmaceutical sector.
Professional Experience in Biopharma
Ana has extensive experience in the biopharmaceutical industry, having worked as a Project Leader at The Boston Consulting Group from 2017 to 2021. Her role focused on biopharma, where she contributed to various strategic initiatives. Prior to that, she held a position as a Postdoctoral Research Fellow at Harvard Medical School and Massachusetts General Hospital from 2013 to 2016, gaining valuable insights into medical research and operational strategies.
Educational Background
Ana completed her Doctor of Philosophy (Ph.D.) in Vascular Physiology at Newcastle University from 2008 to 2012. She also holds a Bachelor of Science in Medical Biochemistry from The University of Sheffield, which she obtained from 2004 to 2008. Earlier, she studied at Lycee International, where she achieved the French 'Baccalauréat général' and German 'Abitur' from 1992 to 2004.
International Experience
Ana has gained international experience in research and commercial strategy across multiple countries, including the United States, Italy, and Germany. Her work at The Boston Consulting Group as a BCG Fellow in 2016 in Florence, Italy, provided her with insights into international business practices and strategies in the biopharmaceutical field.
Research Expertise
With over a decade of academic research experience, Ana has worked in various therapeutic areas. Her background includes significant research roles, particularly during her time as a Postdoctoral Research Fellow and her Ph.D. candidacy. This experience has equipped her with a deep understanding of operational strategy within the biopharmaceutical industry.